[go: up one dir, main page]

SU1475668A1 - Method of treating functional lesions of facial nerve - Google Patents

Method of treating functional lesions of facial nerve Download PDF

Info

Publication number
SU1475668A1
SU1475668A1 SU874266746A SU4266746A SU1475668A1 SU 1475668 A1 SU1475668 A1 SU 1475668A1 SU 874266746 A SU874266746 A SU 874266746A SU 4266746 A SU4266746 A SU 4266746A SU 1475668 A1 SU1475668 A1 SU 1475668A1
Authority
SU
USSR - Soviet Union
Prior art keywords
nerve
facial nerve
muscles
treating functional
treatment
Prior art date
Application number
SU874266746A
Other languages
Russian (ru)
Inventor
Владимир Семенович Лобзин
Нина Давидовна Цацкина
Original Assignee
Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова filed Critical Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова
Priority to SU874266746A priority Critical patent/SU1475668A1/en
Application granted granted Critical
Publication of SU1475668A1 publication Critical patent/SU1475668A1/en

Links

Landscapes

  • Magnetic Treatment Devices (AREA)

Abstract

Изобретение относитс  к области медицины, а именно к невролгии. Способ лечени  функциональных поражений лицевого нерва позвол ет сократить сроки лечени  за счет использовани  миографического контрол  за управл емым активным сокращением мышц, иннервируемых этим нервом на фоне снижени  потреблени  кислорода ткан ми с помощью медикаментозных средств.This invention relates to the field of medicine, namely neurogia. The method of treatment of functional lesions of the facial nerve reduces the duration of treatment due to the use of myographic monitoring of the controlled active contraction of the muscles innervated by this nerve while reducing the oxygen consumption of the tissues using medicaments.

Description

Изобретение относитс  к медицине, а именно к невропатологии.The invention relates to medicine, namely to neuropathology.

Целью изобретени   вл етс  сокращение сроков лечени  за счет проведени  восстановительного лечени  при снижении потреблени  кислорода ткан ми с помощью медикаментозных средств.The aim of the invention is to reduce the time of treatment due to the provision of rehabilitation treatment while reducing the oxygen consumption of the tissues with the help of medicaments.

Способ осуществл ют следующим образом .The method is carried out as follows.

Больному за 30-40 мин до проведени  сеанса восстановительного лечени  путем тренировки с использованием электромиографической обратной св зи, внутримышечно ввод т пираце- там (50 мг/кг веса в сутки) и аевит (1 мл). Затем на двигательные точки тренируемых мышц (лобна , круговые мышцы глаза и рта) симметрично с двух сторон накладывают бипол рные отвод щие электроды с межэлектродным рассто нием 1,5 см. Показатели электрической активности мышц демонстрируют больному на экране злектромнс- графа. Производ т запись электрогене- за произвольных движений мьшщ лба, глаза, рта, регистрируют биопотенциалы при образном представлении о выполнении движений и затем при сочетании самоприказа к движению с образным представлением о движении.The patient, 30–40 minutes before conducting a rehabilitation treatment session by training using electromyographic feedback, is injected intramuscularly with pyraceta (50 mg / kg of body weight per day) and aevit (1 ml). Then, on both sides of the motor points of the trained muscles (the frontal, circular muscles of the eye and mouth) impose bipolar discharge electrodes with an electrode spacing of 1.5 cm. The electrical activity indicators of the muscles are shown to the patient on the electromography graph. The electrogenesis of voluntary movements of the forehead, eye, mouth is recorded, biopotentials are recorded with a figurative representation of the implementation of motions and then with a combination of self-order to movement with a figurative representation of movement.

Курс лечени  - 0 сеансов, проводимых ежедневно по 15 - 20 мин каж дый.The course of treatment is 0 sessions, carried out daily for 15–20 minutes each.

Пример. Больной К., 24 лет, поступил в клинику 04.10.86 года с типичной клинической картиной острого неврита левого лицевого нерва Заболевание развилось за 6 дней до поступлени . Вы влен глубокий пернйе- рический прозопопарез слева: груба  асимметри  лица, левый глаз не закрываетс , слезоточит, нарушен вкус на передних двух трет х  зыка. С первого дн  поступлени  в клинику боль 1Example. Patient K., 24 years old, was admitted to the hospital on 10/04/86 with a typical clinical picture of acute neuritis of the left facial nerve. The disease developed 6 days before admission. You have a deep pernier prostate puncture on the left: a rough asymmetry of the face, the left eye does not close, tears, the taste on the front two-thirds of the tongue is disturbed. From the first day of admission to the clinic, pain 1

сдsd

3d3d

0000

,,

314756684314756684

Claims (1)

ному проводили внутримышечные инъек-Формула изобретени  ции пирацетама (3000 мг) и аевита Способ лечени  функциональныхIntramuscular injections were performed. Formula of the invention of piracetam (3000 mg) and aevit. A method for treating functional (1 мл) за 40 мин до тренировки ЭМГ-ОСпоражений лицевого нерва, включающий(1 ml) 40 minutes before workout of the EMG-OSDs of the facial nerve, including лобной и круговых мышц глаза и рта. -миографический контроль за управл вКурс лечени  -10 сеансов, прово-мым активным сокращением мышц, иннер™frontal and circular muscles of the eyes and mouth. -miographical control of a control in a treatment course of -10 sessions, through active muscle contraction, inner ™ димых ежедневно по 15 мин кау-вируемых этим нервом, отличаюдый .щ и и с   тем, что, с целью сокраще; ,ни  сроков лечени , воздействие осуБольной выписан через 10 дней с JQществл ют при снижении потреблени daily for 15 min each day, which are nerve-ka-guided by this nerve, are distinguished by the fact that, in order to reduce it; nor the treatment time, the effect of the patient was discharged after 10 days with JQ occur while reducing the consumption полным восстановлением функции мими-кислорода ткан ми с помощью медикаческих мышц левой половины лица.ментозных средств.full restoration of the function of mimic oxygen by the tissues with the help of the medical muscles of the left half of the face.
SU874266746A 1987-06-23 1987-06-23 Method of treating functional lesions of facial nerve SU1475668A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU874266746A SU1475668A1 (en) 1987-06-23 1987-06-23 Method of treating functional lesions of facial nerve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU874266746A SU1475668A1 (en) 1987-06-23 1987-06-23 Method of treating functional lesions of facial nerve

Publications (1)

Publication Number Publication Date
SU1475668A1 true SU1475668A1 (en) 1989-04-30

Family

ID=21312702

Family Applications (1)

Application Number Title Priority Date Filing Date
SU874266746A SU1475668A1 (en) 1987-06-23 1987-06-23 Method of treating functional lesions of facial nerve

Country Status (1)

Country Link
SU (1) SU1475668A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029155A1 (en) * 1996-12-28 1998-07-09 Alexandr Alexandrovich Lantsov Method for treating peripheral affections of the facial nerve

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Jankel W.R. Bell Palsy Muscle Reeducation by EMG fredback - Arch, Phys. Med Rehabil, 1978, vol. 59, p.240-242. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029155A1 (en) * 1996-12-28 1998-07-09 Alexandr Alexandrovich Lantsov Method for treating peripheral affections of the facial nerve

Similar Documents

Publication Publication Date Title
Rushton Electrical stimulation in the treatment of pain
Rainey et al. Electrical pacing of the paralyzed human larynx
Dimitrijevic et al. Spasticity: medical and surgical treatment
SU1475668A1 (en) Method of treating functional lesions of facial nerve
RU2412728C2 (en) Method of treating and rehabilitation of patients with severe injuries of radial nerve
Friedman et al. Treatment of spastic dysphonia without nerve section
Jenkner Peripheral Nerve Block: Pharmacologic—By Local Anesthesia Electric—By Transdermal Stimulation
FURST et al. The electrical shock treatment of psychoses
RU2337725C2 (en) Method of peripheral nerve damage treatment
RU2157265C1 (en) Method for treating ischemic cerebral insults
SU782815A1 (en) Method of treating spinal column osteochondrosis and joint arthrosis
RU2202382C2 (en) Method for treating the cases of bronchial asthma and obstructive bronchitis
JP2700242B2 (en) Disease treatment equipment
Orofino The etiology of congenital clubfoot
Cook et al. Radiofrequency stimulation of the trigeminal complex in tic douloureux and atypical facial neuralgia: temporary percutaneous and permanent methods
SU1683757A1 (en) Method for therapy of facial nerve neuropathy
SU806035A1 (en) Method of treating senestopatic syndrome
RU2045291C1 (en) Method for treating polyneuropathy
SU1242186A1 (en) Method of treatment of tobacco smoking
SU1635998A1 (en) Myotonic dystrophy treatment method
SU1107875A1 (en) Method of treatment of patients ill with painful syndromes of oral cavity organs
RU1805964C (en) Method for working capacity increasing
Laitinen Inhibition of cutaneous nociception by deep musculoskeletal pain. A clinical observation
SU1736508A1 (en) Method for treating cerebral venous dystonia
SU1377115A1 (en) Method of treatment of syndrome of parkinsonism